PHOENIX--(BUSINESS WIRE)--Pete Pharma, a pharmaceutical innovation and IP development company focused on modernizing dosage forms through advanced 3D pharmaceutical printing, delivery systems, and scalable manufacturing platforms, today announced a strategic distribution and commercialization partnership with Fagron, Inc., a global leader in pharmaceutical compounding and personalized medicine. Under the terms of the agreement, Fagron has been appointed as an exclusive reseller of Pete Pharma’s
2026 Copyright © News-Matic.com. All Rights Reserved
